Skip to main content

Month: June 2024

Lleida.net signs a 720,000 euro contract with Bosch Telematic Services for 3 years

Madrid, June 18th. The Spanish listed company Lleida.net (BME:LLN) (EPA:ALLLN) (OTCQX:LLEIF) has signed a contract with Bosch Telematic Services for a total amount of 720,000 euros and for a period of 3 years.  According to the contract framework, the technology company will provide the German company with Certified Electronic Contracting and Notification services to perform online contracting processes, accept agreements quickly and easily, and issue certified electronic communications with legal validity.  Bosch Telematic Services is a suite of in-vehicle services from Bosch that offers a wide range of functions to improve driving safety, comfort and efficiency.  Sisco Sapena, CEO of the company Lleida.net, highlighted that, “the signing of this new contract with Bosch Telematic Services for 3 years is a great opportunity to...

Continue reading

Santhera Secures up to CHF 69 million in Royalty and Debt Financing to Fund Operations to Cash Flow Break-Even

Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on June 19, 2024, at 14:00 CEST / 13:00 BST / 08:00 EDT. Details are at the end of this news release.Funding underpins the advancement of AGAMREE® (vamorolone) roll-out and growth in Europe and the pursuit of further developmental initiatives Financing includes up to USD 38 million from R-Bridge, an affiliate of CBC Group, in exchange for a partial monetization of royalty payments received by Santhera in North America and China Santhera also received a commitment for a CHF 35 million senior secured term loan from Highbridge, subject to customary conditions Near-term maturing private convertible bonds to be converted (CHF 4 million) or extended (CHF 7 million) to August 2025 Proceeds from financing to be used to repay listed convertible bonds maturing August...

Continue reading

EUROAPI and Priothera enter into CDMO collaboration to advance oncology project

            Press Release     EUROAPI and Priothera, a biotechnology company specializing in the treatment of hematological malignancies and the improvement of CAR-T cell therapies, have signed a 5-year CDMO agreement EUROAPI will develop and industrialize the manufacturing process of innovative complex molecule for blood cancersParis – June 18, 2024 – EUROAPI announces today the implementation of a 5-year development and manufacturing agreement with Priothera, a biotechnology company specializing in molecules for the treatment of hematological malignancies and for the improvement of CAR-T cell therapies. Priothera is headquartered in Dublin, Ireland, and has a subsidiary in Saint-Louis (Haut-Rhin), France. As part of this collaboration, EUROAPI will develop and industrialize the manufacturing process of mocravimod, an innovative...

Continue reading

Itron Prices Upsized $700 Million 1.375% Convertible Senior Notes Offering

LIBERTY LAKE, Wash., June 17, 2024 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI) (the “Company”), which is innovating new ways for utilities and cities to manage energy and water, today announced the pricing of its private offering of $700 million aggregate principal amount of its 1.375% convertible senior notes due 2030 (the “Notes”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from the previously announced offering size of $500 million aggregate principal amount of Notes. The Company also granted the initial purchasers of the Notes an option to purchase, for settlement during a 13-day period beginning on, and including the first day the Notes are issued, an additional $105 million aggregate...

Continue reading

CARBIOS and TOMRA Textiles join forces to scale circularity of polyester textiles

CARBIOS Tomra Textiles(L-R) Mathieu BERTHOUD, Strategic Sourcing Director, CARBIOS; Vibeke KROHN, Head of TOMRA Textiles;Emmanuel LADENT, CEO, CARBIOS; Mari Larsen SÆTHER, Recycling Lead, TOMRA TextilesCARBIOS and TOMRA Textiles will collaborate to close the textiles circularity gap between collection of textile waste and innovative technologies for textile-to-textile recycling Oslo/Clermont-Ferrand, Tuesday 18 June 2024 (6.45am CEST): CARBIOS (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and TOMRA Textiles, a tech venture set up by sorting technology leader TOMRA (Oslo Stock Exchange: TOM.OL), announce the signing of an agreement to collaborate on establishing an efficient stream in Northern Europe from textile...

Continue reading

Magna Awarded Reconfigurable Seating Business With Chinese OEM

Innovative system offers two rows of seats on long rails with a fully rotating front row Flexible layout for more in-cabin space Award showcases local R&D, complete technology development, and production readinessAURORA, Ontario, June 18, 2024 (GLOBE NEWSWIRE) — For more than 65 years, Magna has helped redefine the very concept of consumer experience and design in the vehicle. Today, the company has further advanced traditional in-cabin vehicle design with its first awarded contract to deliver a reconfigurable seating system to a Chinese OEM. This innovative technology offers fully rotating front seats paired with long rails, enabling a flexible layout for more in-cabin space. Magna’s reconfigurable seating system allows the vehicle to adapt to the consumer, instead of forcing the consumer to adapt to the vehicle. The integration...

Continue reading

Sulliden Announces Board Changes

TORONTO, June 17, 2024 (GLOBE NEWSWIRE) — Sulliden Mining Capital Inc. (TSX: SMC) (“Sulliden” or the “Company”) is pleased to announce that Indivar Pathak has been appointed as a director of the Company, effective immediately. The appointment of Mr. Pathak follows the resignation of Peter Hooper as a director of the Company. The board and management of Sulliden express their gratitude to Mr. Hooper for his efforts and contributions and wish him well in his future endeavours. About Sulliden Sulliden is a mining company focused on acquiring and advancing brownfield, development-stage, and early production-stage mining projects. Sulliden Mining Capital Inc.On behalf of the Board“Scott Moore”, Chief Executive Officerinfo@sulliden.com(416) 861-2267 THE TSX HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OF THIS...

Continue reading

AMC Networks Inc. Announces Pricing of $125 Million Offering of Convertible Senior Notes

NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) — AMC Networks Inc. (Nasdaq: AMCX) (the “Company” or “AMC Networks”) today announced the pricing of $125 million aggregate principal amount of 4.25% convertible senior notes due 2029 in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the offering of the notes, the Company has granted the initial purchasers an option to purchase, for settlement within a 13-day period beginning on, and including, the first day on which the notes are issued, up to an additional $18.75 million aggregate principal amount of the notes. The offering of the notes is expected to close on June 21, 2024, subject to satisfaction of customary closing conditions. AMC Networks...

Continue reading

Afamelanotide in fair-skinned Parkinson’s patients

Preclinical models show benefit of afamelanotide as MC1R therapy in Parkinson’s Disease MELBOURNE, Australia, June 18, 2024 (GLOBE NEWSWIRE) — CLINUVEL today announced a novel clinical program evaluating afamelanotide as a treatment in early-stage Parkinson’s Disease (PD or Parkinson’s) in fair-skinned patients. The program objectives are to determine whether afamelanotide – through melanocortin-1 receptor (MC1R) activation – is able to lower α-synuclein (a toxin) in blood levels in PD patients, and positively affect neurons of the midbrain. MC1R is known to be a key receptor in brain and skin cells. In large studies, it was found that fair-skinned patients have a higher risk of PD associated with a malfunctioning MC1R.a, 1-2 Since afamelanotide is known to optimise the function of the MC1R, it is hypothesised that the drug treatment...

Continue reading

Purpose Investments Inc. Announces June 2024 Distributions

TORONTO, June 17, 2024 (GLOBE NEWSWIRE) — Purpose Investments Inc. (“Purpose”) is pleased to announce distributions for the month of June 2024 for its open-end exchange-traded funds and closed-end funds (“the Funds”). The ex-distribution date for all Open-End Funds is June 26, 2024. The ex-distribution date for all Closed-End Funds is June 28, 2024.Open-End Funds Ticker Symbol Distribution per share/unit Record Date Payable Date Distribution FrequencyApple (AAPL) Yield Shares Purpose ETF – ETF Units APLY $0.1667 06/26/2024 07/03/2024 MonthlyPurpose Canadian Financial Income Fund – ETF Series BNC $ 0.1225¹ 06/26/2024 07/03/2024 MonthlyPurpose Global Bond Fund – ETF Units BND $0.0712 06/26/2024 07/03/2024 MonthlyBerkshire Hathaway (BRK) Yield Shares Purpose ETF – ETF Units BRKY $0.1000 06/26/2024 07/03/2024 MonthlyPurpose...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.